Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 382-389

  Nunes, Jorge Meneses ^a   Bizerra, Fernando César ^a   Carmona E Ferreira, Renata ^a   Colombo, Arnaldo Lopes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CRYSTAL VIOLET; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANKTON; PRIORITY JOURNAL; RHODOSPORIDIUM; RHODOSPORIDIUM DAIRENENSIS; RHODOSPORIDIUM FLUVIALE; RHODOSPORIDIUM GLUTINIS; RHODOSPORIDIUM MINUTA; RHODOSPORIDIUM MUCILAGINOSA; RHODOSPORIDIUM SLOOFFIAE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; DNA, RIBOSOMAL SPACER; FUNGEMIA; GENTIAN VIOLET; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; PHYLOGENY; PLANKTON; RHODOTORULA; SEQUENCE ANALYSIS, DNA; SOIL MICROBIOLOGY; SPECIES SPECIFICITY;

EID: 84872036500     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01647-12     Document Type: Article

References (37)

1. Cordeiro RA, Brilhante RSN, Pantoja LDM, Filho M, Vieira RN, Rocha MFG, Sidrim JC. 2010. Isolation of pathogenic yeasts in the air from hospital environments in the city of Fortaleza, northeast Brazil. Braz. J. Infect. Dis. 14:30-34.
2. Galán-Sánchez F, García-Martos P, Rodríguez-Ramos C, Marín-Casanova P, Mira-Gutiérrez J. 1999. Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples. Mycopathologia 145:109-112.
3. Silva V, Zepeda G, Eugenia M, Febré N. 2003. Yeast carriage on the hands of medicine students. Rev. Iberoam. Micol. 20:41-45. (In Spanish.)
4. Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. 2005. Activities of available and investigational antifungal agents against Rhodotorula species. J. Clin. Microbiol. 43:476-478.
5. Hazen KC. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
6. Miceli MH, Díaz JA, Lee SA. 2011. Emerging opportunistic yeast infections. Lancet Infect. Dis. 11:142-151.
7. Tuon FF, Costa SF. 2008. Rhodotorula infection. A systematic review of 128 cases from literature. Rev. Iberoam. Micol. 25:135-140.
8. Nucci M, Anaissie E. 2006. Emerging fungi. Infect. Dis. Clin. North Am. 20:563-579.
9. De Almeida GMD, Costa SF, Melhem M, Motta AL, Szeszs MW, Miyashita F, Pierrotti LC, Rossi F, Burattini MN. 2008. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med. Mycol. 46:547-556.
10. Savini V, Sozio F, Catavitello C, Talia M, Manna A, Febbo F, Balbinot A, Di Bonaventura G, Piccolomini R, Parruti G, D'Antonio D. 2008. Femoral prosthesis infection by Rhodotorula mucilaginosa. J. Clin. Microbiol. 46:3544-3545.
11. Unal A, Koc AN, Sipahioglu MH, Kavuncuoglu F, Tokgoz B, Buldu HM, Oymak O, Utas C. 2009. CAPD-related peritonitis caused by Rhodotorula mucilaginosa. Perit. Dial. Int. 29:581-582.
12. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi M. 2009. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol. 47:117-123.
13. Chagas-Neto TC, Chaves GM, Colombo AL. 2008. Update on the genus Trichosporon. Mycopathologia 166:121-132.
14. Ciardo DE, Schär G, Böttger EC, Altwegg M, Bosshard PP. 2006. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J. Clin. Microbiol. 44:77-84.
15. GarcíA-Martos P, GarcíA-Agudo L, Ruiz-Aragón J, Saldarreaga A, Marín P. 2004. Carbohydrate assimilation by clinical and environmental Rhodotorula glutinis strains. Rev. Iberoam. Micol. 21:90-92. (In Spanish.)
16. Meletiadis J, Arabatzis M, Bompola M, Tsiveriotis K, Hini S, Petinaki E, Velegraki A, Zerva L. 2011. Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates. J. Clin. Microbiol. 49:2722-2727.
17. Silva JO, Candido RC. 2005. Evaluation of the API20C AUX system for the identification of clinically important yeasts. Rev. Soc. Bras. Med. Trop. 38:261-263. (In Portuguese.)
18. de Hoog GS, Guarro J, Gené J, Figueras MJ. 2000. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
19. Fell JW, Statzell-Tallman A. 1998. Rhodotorula F. C. Harrison, p 800-827. In Kurtzman P, Fell JW (ed), The yeasts: a taxonomic study, 4th ed. Elsevier, New York, NY.
20. Wach A, Pick H, Philippsen P. 1994. Procedures for isolating yeast DNA for different purposes, p 10-11. In Johnston JR (ed), Molecular genetics of yeast: a practical approach. Oxford University Press, Oxford, United Kingdom.
21. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A. 74:5463-5467.
22. Souza ACR, Ferreira RC, Gonçalves SS, Quindós G, Eraso E, Bizerra FC, Briones MRS, Colombo AL. 2012. Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR. J. Clin. Microbiol. 50:2310-2314.
23. Isenberg HD. 1998. Nitrate assimilation test for identification of yeasts to the species level, p 311-312. In Isenberg HD (ed), Essential procedures for clinical microbiology. ASM Press, Washington, DC.
24. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
25. Melo AS, Bizerra FC, Freymüller E, Arthington-Skaggs BA, Colombo AL. 2011. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med. Mycol. 49:253-262.
26. Bizerra FC, Nakamura CV, de Poersch C, Estivalet Svidzinski TI, Borsato Quesada RM, Goldenberg S, Krieger MA, Yamada-Ogatta SF. 2008. Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res. 8:442-450.
27. Pasqualotto GC, Copetti FA, Meneses CF, Machado ARL, Brunetto AL. 2005. Infection by Rhodotorula sp. in children receiving treatment for malignant diseases. J. Pediatr. Hematol. Oncol. 27:232-233.
28. Samonis G, Anatoliotaki M, Apostolakou H, Maraki S, Mavroudis D, Georgoulias V. 2001. Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature. Infection 29:173-176.
29. Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. 2003. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J. Clin. Microbiol. 41:5233-5235.
30. Tuon FF, de Almeida GMD, Costa SF. 2007. Central venous catheter-associated fungemia due to Rhodotorula spp. - a systematic review. Med. Mycol. 45:441-447.
31. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
32. Hawser SP, Douglas LJ. 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39:2128-2131.
33. Ramage G, Martínez JP, López-Ribot JL. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6:979-986.
34. Brummer E, Restrepo A, Hanson LH, Stevens DA. 1990. Virulence of Paracoccidiodes brasiliensis: the influence of in vitro passage and storage. Mycopathologia 109:13-17.
35. Svidzinski TI, Miranda Neto MH, Santana RG, Fischman O, Colombo AL. 1999. Paracoccidioides brasiliensis isolates obtained from patients with acute and chronic disease exhibit morphological differences after animal passage. Rev. Inst. Med. Trop. Sao Paulo 41:279-283.
36. Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. 2005. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J. Antimicrob. Chemother. 55:312-316.
37. Guinea J, Recio S, Escribano P, Peláez T, Gama B, Bouza E. 2010. In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens. Antimicrob. Agents Chemother. 54:4012-4015.